Preserved Ratio Impaired Spirometry (PRISm) in Mardan: A Retrospective Prevalence Study of Spirometric Patterns and Associated Comorbidities
Keywords:
Preserved Ratio Impaired Spirometry, Spirometry, Pulmonary Function Test, Obstructive Lung DiseaseAbstract
Background: Preserved Ratio Impaired Spirometry (PRISm) is a unique form of spirometric abnormality that is defined as reduced FEV? (<80% predicted) with a preserved FEV?/FVC ratio of ?0.70. Unlike obstructive and restrictive lung disorders, PRISm is increasingly being recognized as a clinically relevant condition that is linked with respiratory symptoms, metabolic syndrome, cardiovascular disease, and increased mortality. Objective: To determine the prevalence of PRISm among adults undergoing spirometry and to find out its relationship with demographic and comorbid factors. Methodology: A retrospective study design was used to examine 180 spirometric results from adult patients (?18 years old) in a tertiary care hospital in Peshawar from January 2023 to December 2024. The variables collected for analysis were age, gender, BMI, smoking status, comorbidities, and spirometric values. PRISm was defined as FEV1 <80% predicted with FEV1/FVC ?0.70. Results: Out of 180 patients, the mean age was 46.7 ± 13.2 years, and 52.2% of them were males. PRISm prevalence was 15.5% (n=28), normal spirometry 51.6% (n=93), and obstructive pattern 32.7% (n=59). PRISm patients had significantly decreased FVC (72.5 ± 6.7%) compared with normal and obstructive patients (p<0.001). PRISm was significantly associated with hypertension (39.2% vs. 21.7%, p=0.024), diabetes mellitus (35.7% vs. 17.7%, p=0.037), and cardiovascular disease (25% vs. 9.8%, p=0.024), diabetes mellitus, and cardiovascular disease (25% vs. 9.8%, p=0.048). Conclusion: PRISm is a common intermediate spirometric phenotype within this population and has been linked with many cardiometabolic comorbidities and obesity. It may be beneficial to recognize this within clinical practice in order to potentially prevent the progression of this into pulmonary and systemic disorders.References
Wan ES, Fortis S, Regan EA, Hokanson J, Han MK, Casaburi R, et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018;198(11):1397-405.
Zhao N, Wu F, Peng J, Zheng Y, Tian H, Yang H, et al. Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity. Respir Res. 2022;23(1):298. DOI: 10.1186/s12931-022-02216-1.
Kaise T, Sakihara E, Tamaki K, Miyata H, Hirahara N, Kirichek O, et al. Prevalence and characteristics of individuals with preserved ratio impaired spirometry (PRISm) and/or impaired lung function in Japan: the OCEAN study. Int J Chron Obstruct Pulmon Dis. 2021:2665-75. DOI:10.2147/COPD.S322041.
Park HJ, Byun MK, Rhee CK, Kim K, Kim HJ, Yoo KH. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study. Respir Res. 2018;19(1):185. DOI:10.1186/s12931-018-0896-7.
Knox-Brown B, Amaral AF, Burney P. Concerns about prism. Lancet Respir Med. 2022;10(6):e51-2. DOI:10.1016/S2213-2600(22)00134-5.
Kanetake R, Takamatsu K, Park K, Yokoyama A. Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry. BMJ Open Respir Res. 2022;9(1). DOI:10.1136/bmjresp-2022-001298.
Myrberg T, Backman H, Stridsman C, Hedman L, Rönmark E, Lindberg A. PRISm is an independent risk factor for development of COPD. Eur Respir J. 2024 64(suppl 68): PA1292; DOI:10.1183/13993003.congress-2024.PA1292.
Perez-Padilla R, Montes de Oca M, Thirion-Romero I, Wehrmeister FC, Lopez MV, Valdivia G, et al. Trajectories of spirometric patterns, obstructive and PRISm, in a population-based cohort in Latin America. Int J Chron Obstruct Pulmon Dis. 2023:1277-85. DOI:10.2147/COPD.S406208.
Cadham CJ, Oh H, Han MK, Mannino D, Cook S, Meza R, et al. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007–2012. Respir Res. 2024;25(1):208. DOI:10.1186/s12931-024-02841-y.
Wijnant SR, De Roos E, Kavousi M, Stricker BH, Terzikhan N, Lahousse L, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1). DOI:10.1183/13993003.01217-2019.
Fortis S, Comellas A, Kim V, Casaburi R, Hokanson JE, Crapo JD, et al. Low FVC/TLC in preserved ratio impaired spirometry (PRISm) is associated with features of and progression to obstructive lung disease. Sci Rep. 2020;10(1):5169. DOI:10.1038/s41598-020-61932-0.
Zhao N, Wu F, Peng J, Zheng Y, Tian H, Yang H, Deng Z, Wang Z, Li H, Wen X, Xiao S. Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity. Respir Res. 2022 Oct 31;23(1):298. DOI: 10.1186/s12931-022-02216-1.
Tang X, Huang K, Chu X, Peng Y, Huang T, Cui Y, Yang T, Wang C. Relationship between diabetes-related clinical characteristics and preserved ratio impaired spirometry (PRISm): findings from NHANES 2007–2012. BMJ Public Health. 2024;2(2). DOI: 10.1136/bmjph-2024-001313.
Huang J, Li W, Sun Y, Huang Z, Cong R, Yu C, Tao H. Preserved ratio impaired spirometry (PRISm): a global epidemiological overview, radiographic characteristics, comorbid associations, and differentiation from chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2024 Dec 31:753-64. DOI:10.2147/COPD.S453086.
Higbee DH, Lirio A, Hamilton F, Granell R, Wyss AB, London SJ, et al. Genome-wide association study of preserved ratio impaired spirometry (PRISm). Eur Respir J. 2024;63(1). DOI:10.1183/13993003.00337-2023.
Wan ES. The clinical spectrum of PRISm. Am J Respir Crit Care Med. 2022;206(5):524-5. DOI:10.1164/rccm.202205-0965ED.
Tran TV, Kinney GL, Comellas A, Hoth KF, Baldomero AK, Mamary AJ, et al. Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. Respir Med. 2023;208:107126. DOI:10.1016/j.rmed.2023.107126.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


